FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310987534> ?p ?o ?g. }

• W4310987534 abstract "To investigate the role of immune escape encoding genes on the prognosis of BC, and to predict the novel targeting agents.Human immune genes and immune escape encoding genes were obtained from the IMMPORT database and the previous study. Sample information and clinical data on BC were obtained from the TCGA and GTEX databases. Obtaining differentially expressed protein data from cBioportal database. To construct a risk score model by lasso analysis, and nomogram was used to predict score core. GSCA, TIMER and CELLMINER databases were used for immune and drug susceptibility correlation analyses. Cell experiments were verified by MTT, Western blotting, and RT-qPCR.We found prognostic models consisting of eleven immune escape related protein-coding genes with ROC curves that performed well in the ontology data (AUC for TCGA is 0.672) and the external data (AUC for GSE20685 is 0.663 and for GES42568 is 0.706). Five core prognostic models are related to survival (EIF4EBP1, BCL2A1, NDRG1, ERRFI1 and BRD4) were summarized, and a nomogram was constructed to validate a C-index of 0.695, which was superior to other prognostic models. Relevant drugs targeting core genes were identified based on drug sensitivity analysis, and found that Vemurafenib downregulates the PI3K-AKT pathway and BCL2A1 protein in BC, as confirmed by external data and cellular assays.Briefly, our work establishes and validates an 11-immune escape risk model, and five core prognostic factors that are mined deeply from this model, and elucidates in detail that Vemurafenib suppresses breast cancer by targeting the PI3K/AKT signaling pathway to inhibit the immune escape biomarker BCL2A1, confirms the validity of the prognostic model, and provides corresponding targeted agents to guide individualized treatment of BC patients." @default.
• W4310987534 created "2022-12-22" @default.
• W4310987534 creator A5001713932 @default.
• W4310987534 creator A5011594561 @default.
• W4310987534 creator A5024135429 @default.
• W4310987534 creator A5025575277 @default.
• W4310987534 creator A5030906930 @default.
• W4310987534 creator A5034306435 @default.
• W4310987534 creator A5035163240 @default.
• W4310987534 creator A5038002804 @default.
• W4310987534 creator A5039545694 @default.
• W4310987534 creator A5044119010 @default.
• W4310987534 creator A5048341648 @default.
• W4310987534 creator A5056194253 @default.
• W4310987534 creator A5064840965 @default.
• W4310987534 creator A5064848746 @default.
• W4310987534 creator A5067451569 @default.
• W4310987534 creator A5070902065 @default.
• W4310987534 creator A5076409244 @default.
• W4310987534 creator A5089474387 @default.
• W4310987534 date "2022-11-29" @default.
• W4310987534 modified "2023-09-26" @default.
• W4310987534 title "Vemurafenib inhibits immune escape biomarker BCL2A1 by targeting PI3K/AKT signaling pathway to suppress breast cancer" @default.
• W4310987534 cites W1846586690 @default.
• W4310987534 cites W18714953 @default.
• W4310987534 cites W1971133173 @default.
• W4310987534 cites W1978354618 @default.
• W4310987534 cites W1993804787 @default.
• W4310987534 cites W2004630197 @default.
• W4310987534 cites W2025738474 @default.
• W4310987534 cites W2028113479 @default.
• W4310987534 cites W2044702943 @default.
• W4310987534 cites W2096283457 @default.
• W4310987534 cites W2103196126 @default.
• W4310987534 cites W2114843025 @default.
• W4310987534 cites W2114901348 @default.
• W4310987534 cites W2157497892 @default.
• W4310987534 cites W2257916459 @default.
• W4310987534 cites W2272715130 @default.
• W4310987534 cites W2318725321 @default.
• W4310987534 cites W2473526019 @default.
• W4310987534 cites W2560367415 @default.
• W4310987534 cites W2578528809 @default.
• W4310987534 cites W2598705813 @default.
• W4310987534 cites W2609651208 @default.
• W4310987534 cites W2739309812 @default.
• W4310987534 cites W2744067212 @default.
• W4310987534 cites W2750541839 @default.
• W4310987534 cites W2765224588 @default.
• W4310987534 cites W2782635154 @default.
• W4310987534 cites W2800887733 @default.
• W4310987534 cites W2804658429 @default.
• W4310987534 cites W2884727950 @default.
• W4310987534 cites W2900679912 @default.
• W4310987534 cites W2912993657 @default.
• W4310987534 cites W2918171974 @default.
• W4310987534 cites W2945861626 @default.
• W4310987534 cites W2949273159 @default.
• W4310987534 cites W2982479866 @default.
• W4310987534 cites W3009386543 @default.
• W4310987534 cites W3044291566 @default.
• W4310987534 cites W3088246260 @default.
• W4310987534 cites W3126367581 @default.
• W4310987534 cites W3128646645 @default.
• W4310987534 cites W3149814425 @default.
• W4310987534 cites W4211032970 @default.
• W4310987534 doi "https://doi.org/10.3389/fonc.2022.906197" @default.
• W4310987534 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36524001" @default.
• W4310987534 hasPublicationYear "2022" @default.
• W4310987534 type Work @default.
• W4310987534 citedByCount "0" @default.
• W4310987534 crossrefType "journal-article" @default.
• W4310987534 hasAuthorship W4310987534A5001713932 @default.
• W4310987534 hasAuthorship W4310987534A5011594561 @default.
• W4310987534 hasAuthorship W4310987534A5024135429 @default.
• W4310987534 hasAuthorship W4310987534A5025575277 @default.
• W4310987534 hasAuthorship W4310987534A5030906930 @default.
• W4310987534 hasAuthorship W4310987534A5034306435 @default.
• W4310987534 hasAuthorship W4310987534A5035163240 @default.
• W4310987534 hasAuthorship W4310987534A5038002804 @default.
• W4310987534 hasAuthorship W4310987534A5039545694 @default.
• W4310987534 hasAuthorship W4310987534A5044119010 @default.
• W4310987534 hasAuthorship W4310987534A5048341648 @default.
• W4310987534 hasAuthorship W4310987534A5056194253 @default.
• W4310987534 hasAuthorship W4310987534A5064840965 @default.
• W4310987534 hasAuthorship W4310987534A5064848746 @default.
• W4310987534 hasAuthorship W4310987534A5067451569 @default.
• W4310987534 hasAuthorship W4310987534A5070902065 @default.
• W4310987534 hasAuthorship W4310987534A5076409244 @default.
• W4310987534 hasAuthorship W4310987534A5089474387 @default.
• W4310987534 hasBestOaLocation W43109875341 @default.
• W4310987534 hasConcept C121608353 @default.
• W4310987534 hasConcept C126322002 @default.
• W4310987534 hasConcept C143998085 @default.
• W4310987534 hasConcept C203014093 @default.
• W4310987534 hasConcept C2776131300 @default.
• W4310987534 hasConcept C2777658100 @default.
• W4310987534 hasConcept C2994587330 @default.
• W4310987534 hasConcept C34626388 @default.
• W4310987534 hasConcept C502942594 @default.

• next